electroCore Submits Emergency Use Authorization Application to Allow the Study and Use of gammaCore nVNS Therapy to Treat Respiratory Symptoms Associated with COVID-19
Stock Information for electroCore Inc.
Loading
Please wait while we load your information from QuoteMedia.